Maiwald in the press
Press Coverage
Another success for Maiwald and betapharm Arzneimittel GmbH
We are happy to report that the oppositions filed by our client betapharm and eight other generics manufacturers against Novartis patent EP 3 351 246 were successful; the Board of Appeal of the European Patent Office revoked the Novartis patent for lack of inventive step (fi...
Continue reading
Novartis Fingolimod patent declared invalid by Federal Patent Court in first instance
At the end of June, the Federal Patent Court declared a Novartis patent (EP 3 143 990 B1) null and void in its entirety for lack of inventive step (file no. : 3 Ni 13/22). Novartis ma...
Continue reading
LTS expands into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
Andernach, Germany - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (“TTS”), Oral Thin Films (“OTF”) and Micro Array...
Continue reading
All press coverage
